Cepheid公司宣布FDA已经批准其开发的新一代针对抗甲氧西林—金黄色葡萄球菌(MRSA)感染快速检测设备Xpert MRSA Nx G上市,用于对抗近年来愈演愈烈的MRSA传播情况。该设备是一种基于该公司独有的分子检测方法平台Gene Xpert为基础构建而成的新型检测设备,能够在一小时内迅速检测出患者是否受到了MRSA的感染。Xpert MRSA Nx G的开发人员是通过构建了一个包含全球各地MRSA菌株文库为基础开发出这一产品, Cepheid announced that FDA has approved the launch of a new generation of its Xpert MRSA Nx G anti-methicillin-resistant Staphylococcus aureus (MRSA) rapid detection device to combat the spread of MRSA in recent years. The device is a new testing device based on Gene Xpert, the company’s unique molecular testing platform that quickly detects if an individual is infected with MRSA within an hour. Developers at Xpert MRSA Nx G developed the product by building a library of MRSA strains from around the world,